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European Journal of Cardio-thoracic Surgery 40 (2011) 978—984AbstractObjective: To determine if cardiopulmonary bypass (CPB), together with inhibition of the sodium—hydrogen exchanger (NHE), limits
myocardial and neurological injury and improves recovery after prolonged (unwitnessed) cardiac arrest (CA), as NHE inhibition improved
recovery after deep hypothermic circulatory arrest. Methods: Twenty-seven pigs (31—39 kg) underwent 15 min of prolonged (no-flow) CA
followed by 10 min of cardiopulmonary resuscitation-advanced life support (CPR-ALS). Subjects with restoration of spontaneous circulation
(ROSC) during CPR-ALS received either no drug (n = 6) or an inhibitor of the NHE (HOE-642; n = 5). In the 16 unsuccessfully resuscitated animals,
peripheral normothermic CPB was instituted, and either no drug (n = 9) or similar HOE-642 (n = 7) therapy started. Hemodynamic data, a species-
specific neurological deficit score (0 = normal to 500 = brain death), and mortality were recorded at 24 h, and biochemical variables of organ
injury measured. Results: CPR-ALS restored ROSC in 41% (11/27) of animals, but was unsuccessful in 59% (16/27) that required CPB. Without CPB,
HOE-642 increased cardiac index and decreased vascular resistance; with CPB, HOE-642 caused higher pump flows (3.4  0.6 l min1 m2 vs
2.5  0.7 l min1 m2; p < 0.001) and higher post-arrest cardiac index; but animals required more vasopressors (p = 0.019) from drug-induced
vasodilation. No differences between biochemical markers of oxidative and organ injury and overall 24-h mortality (20%) were found between
groups. Neurological score was improved at 24 h compared with 4 h only after HOE-642 treatment with (150  34 vs 220  43; p = 0.003) or
without CPB (162  39 vs 238  48; p  0.001), but failed to reach statistical difference with respect to the untreated group. Conclusions: CPB is
an effective resuscitative tool to treat prolonged CA but there is limited improvement of neurological function. NHE inhibition augments cardiac
and neurological function, but its effect was less pronounced than in other studies.
# 2011 Published by Elsevier B.V. on behalf of European Association for Cardio-Thoracic Surgery.
Keywords: Cardiac arrest; Cardiopulmonary resuscitation; Cardiopulmonary bypass; Sodium—hydrogen exchanger (NHE) inhibition1. Introduction
Brain injury and its sequelae in post-resuscitation
survivors remain an unsolved problem that exists, despite
our capacity to restore heart function in a limited number of
instances [1,2]. To circumvent inadequate systemic perfu-
sion, cardiopulmonary bypass (CPB) as a resuscitative tool has
been repeatedly investigated in experimental [3] and clinical
studies [4], with promising results. Experimental studies
demonstrate 80—100% survival using CPB after 5—10 min of
cardiac arrest (CA) [3]. Clinically, up to 40% survival has been§ This work was supported by a grant from the National Institutes of Health
(R01-HL-71729-04).
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 byejcts.ctsnetjournals.orgDownloaded from reported after in-hospital CA, when CPB was established
after unsuccessful cardiopulmonary resuscitation (CPR)
[4,5]. Compared with CPR-advanced life support (CPR-
ALS), CPB facilitates stable restoration of cerebral and
cardiac blood flow, and may allow recovery of the stunned
myocardium even after prolonged ischemic periods [3—5].
We have recently reported a 64% 24-h survival using
normothermic CPB after 15 min of prolonged CA that was
unresponsive to CPR-ALS in pigs [6]. However, despite
improved survival with CPB, hypoxic brain injury was present
in all animals, and was coupled to severe neurological
impairment.
CPB provides the unique opportunity to apply known
principles of controlled reperfusion to improve recovery of
the heart and brain by limiting the post-resuscitation
reperfusion injury after prolonged CA [7,8]. Calcium is one
of the primary mediators of the reperfusion injury of organs,opean Association for Cardio-Thoracic Surgery.
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dysfunction and neuronal cell death [9]. Counteracting
intracellular acidosis after ischemia, the sodium—hydrogen
ion antiporter (NHE) activation leads to sodium overload of
the cell that subsequently promotes intracellular calcium
accumulation. In previous experimental studies, we have
demonstrated markedly improved myocardial and neurolo-
gical recovery by controlling post-ischemic intracellular
calcium accumulation through NHE inhibition with HOE-642
after prolonged deep hypothermic circulatory arrest (DHCA)
[10,11]. The aims of this study were to determine whether
use of CPB as a resuscitation tool and NHE inhibition with
HOE-642 will limit whole-body-reperfusion injury and
improve myocardial and neurological recovery in an experi-
mental model of 15 min no-flow CA.2. Material and methods
The study protocol was approved by the Institutional
Animal Research Committee of the University of California at
Los Angeles, and animals received humane care in com-
pliance with the 1996 NRC Guide for the Care and Use of
Laboratory Animals. The experimental protocol used in this
study has been described in detail previously [6], and is,
therefore, briefly summarized.
After anesthesia and endotracheal intubation, 30 York-
shire—Duroc pigs (31—39 kg) were mechanically ventilated
with respirator settings adjusted to keep oxygen tension,
carbon dioxide tension, and pH values within the normal
range. The left internal thoracic artery was cannulated for
arterial pressure measurements under sterile surgical
techniques. In addition, a balloon-tipped pulmonary artery
catheter (Baxter Healthcare Corp, Irvine, CA, USA) was
inserted via the right subclavian vein to measure cardiac
output (thermodilution technique). After baseline hemody-
namic measurements and systemic heparinization
(300 IE kg1) ventricular fibrillation (VF) was induced by
delivering a 60-Hz (4.5 A) alternating current (AC-Fibrillator,
Medtronic Inc., Minneapolis, MN, USA) to the right ventricular
endocardium using a catheter (Bard, Electrophysiology,
Lowell, MA, USA) that was inserted through the right
subclavian vein.
The resuscitation protocol was initiated at 15 min of CA,
and was in accordance with the CPR-ALS algorithm of the
American Heart Association. Closed-chest CPR was provided
for 10 min, with manual chest compressions at a rate of 80—
100 min1, and manual ventilation with room air at a rate of
12—15 breaths per minute. Defibrillation of VF was
attempted after five CPR cycles with 200 J (Lifepak 9P,
Physio-Control Corp., Redmond, WA, USA), and repeated
after every five CPR cycles with 300—360 J until restoration
of spontaneous circulation. Intravenous epinephrine was
administered every 2—3 min as needed (0.02—
0.04 mg kg1 min1), and lidocaine (1 mg kg1) was given
and repeated until maximal dosage was reached (3 mg kg1).
Manual CPR was performed by two investigators (O.L. and
N.H.) to providemaximal consistency, and coronary perfusion
pressures (CPPs) of >15 mmHg were targeted, as indicated
by the difference of diastolic arterial pressure and central
venous pressure. byejcts.ctsnetjournals.orgDownloaded from In each study, the 10-min CPR-ALS interval was used to
connect the arterial (femoral artery; 12F, Medtronic, Inc.,
Minneapolis, MN, USA) and venous cannulas (jugular vein;
19—21F, Medtronic, Inc., Minneapolis, MN, USA) to the CPB
circuit, consisting of a membrane oxygenator (Affinity NT
541, Medtronic, Inc., Minneapolis, MN, USA), an arterial
roller pump (Sarns, Ann Arbor, MI, USA), and a venous
centrifugal pump (Biopump BPX-80, Medtronic Inc., Minnea-
polis, MN, USA) for active venous suction with a standardized
pump prime (800 ml Plasma-Lyte solution; 700 ml of stored
porcine donor blood; and 100 IU kg1 heparin, normocalce-
mic).
Normothermic, full-flow CPB (100—150 ml kg1 min1)
was initiated, if the 10-min CPR-ALS interval did not
successfully restore stable spontaneous circulatory function
(ROSC), defined as either persistence of ventricular fibrilla-
tion or return of supraventricular rhythm, but inability to
maintain a mean arterial pressure >50 mmHg for 1 min [6].
2.1. Experimental groups
2.1.1. Preliminary studies
In an initial series of three animals, a 5 mg kg1 bolus of
the NHE inhibitor HOE-642 (Aventis Pharma, Frankfurt,
Germany) used previously in our DHCA studies [12,13] was
administered intravenously after 15 min of no-flow CA with
10 min of CPR-ALS (one animal with ROSC; two without ROSC
and subsequent CPB). Severe hypotension due to vasodilation
with acidosis led to the death of the animal with ROSC after
CPR-ALS. In the two CPB subjects, persistent vasodilation
occurred despite CPB, and each subject eventually suc-
cumbed from hypotension and failure to wean from CPB after
175  43 min.
This adverse hemodynamic event led to subsequent
adjustment of the HOE-642 dose to 1 mg kg1 to attenuate
the aforementioned adverse drug effects. The new dose was
then employed in the 27 remaining pigs, whereby HOE-642
was given as a bolus (1 mg kg1) immediately 10 min after
CPR (or put in the bypass prime in subjects placed on CPB),
and followed by a continuous infusion of 1 mg kg1 over
30 min. Thus, data of all three animals receiving the
5 mg kg1 HOE-642 dose were excluded from this study.
2.1.2. CPR with ROSC
If ROSC occurred during the 10 min of CPR-ALS, animals
were randomly assigned to receive either HOE-642 or no
treatment (no Rx).
2.1.3. CPR without ROSC
In animals without ROSC after 10 min of CPR-ALS, CPB was
initiated and either no treatment (CPB and no Rx) or HOE-642
was administered.
CPB management and post-resuscitation care of subjects
was facilitated, as previously reported [6]. After successful
cardioversion of VF on CPB following repeated counter-
shocks, discontinuation of CPB was initiated when sponta-
neous hemodynamic performance maintained mean arterial
pressure >50 mmHg with or without dopamine (5—
10 mg kg1 min1) or norepinephrine (0.01—0.15 mg kg1
min1) support. Systemic heparinization was reversed with
protamine, wounds were closed, and animals were allowed Nikola Hristov on December 22, 2011 
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spontaneous breathing was present. They weremonitored for
24 h after CPB. At the end of the protocol, the animals were
euthanized using 30 mg kg1 pentobarbital and potassium
chloride.
2.2. Hemodynamic and biochemical measurements
Hemodynamicmeasurements weremade before induction
of VF (baseline), and after discontinuation of CPB. Cardiac
output was determined by triplicate injections of 4 8C cold
saline solution, and cardiac index (CI) and systemic and
pulmonary vascular resistance indices (SVRI and PVRI)
calculated. In addition, mean arterial pressure and arterial
pump flow were recorded during CPB for estimation of
systemic vascular resistance. The number of shocks during
CPR, minutes of CPR until cardioversion, and number of
subjects requiring dopamine and/or norepinephrine support
and mortality are summarized.
Arterial blood was sampled at baseline, after CPB, and at 4
and 24 h. Blood samples were immediately centrifuged
(3000 rpm) for 10 min and stored at 20 8C until biochemical
analysis [6]. As a marker of oxidant-mediated lipid peroxida-
tion, conjugated diene (CD) levels were determined spectro-
photometrically. Cellular injury was determined by
creatinine kinase (CK-MB), serum aspartate aminotransfer-
ase (AST), and alanine aminotransferase (ALT) activity using
the ultraviolet (UV)-spectrophotometric method (Sigma
Chemical Co., St. Louis, MO, USA). Enzyme immunometric
assays were performed to measure endothelin-1 (ACE EIA kit,
Cayman Chemical Company, Ann Arbor, MI, USA) for vascular-
and neuron-specific enolase (NSE; SynX Pharma Inc., Toronto,
ON, Canada) for brain injury.
2.3. Neurologic deficit score
Neurologic assessment was performed at 4 and 24 h after
CPB using a species-specific neurological deficit score [6] that
assesses five general components including cranial nerves’
function, respiration, motor and sensory function, conscious-
ness, and behavior. Each category has amaximal score of 100:
0 is normal and 500 indicates brain death. In addition, seizure
activity was recorded. Two laboratory team members graded
neurological function, with mean values recorded for
different evaluations.Table 1. Perioperative variables.
Animals (n) CA (min) CPR (min) Shocks (n) CPB
No Rx 6 15 6.5  1.8 4.0  1.3
HOE-642 5 15 5.8  2.3 4.3  1.1
CPB and no Rx 9 15 10  0 5.8  1.7 73 
CPB and HOE-642 7 15 10  0 6.1  1.3 86 
Perioperative variables of treatment groups subjected to 15 min of cardiac arrest
cardiopulmonary bypass (CPB). Note the longer CPB time and increased vasopre
mean  standard deviation (SD). CA: duration of cardiac arrest; CPR: duration of c
treatment after restoration of stable circulation (ROSC) during CPR-ALS; CPB and no
following unsuccessful CPR-ALS.
* p < 0.05.
# p < 0.05 between treatment groups.
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Data were expressed asmean  standard deviation (SD) or
standard error of mean (SEM) as indicated. Two-way analysis
of variance (ANOVA) for repeated measurements with the
Tukey post hoc procedure was used to analyze intra- and
inter-group differences. Perioperative characteristics of
groups were analyzed by unpaired t-test for continuous data
and x2 or Fisher’s exact test for categorical data. Probability
values <0.05 were considered statistically significant.3. Results
Perioperative variables of treatment groups are summar-
ized in Table 1 and Fig. 1. Low-amplitude VF was present in all
animals after the 15-min period of CA. Restoration of
spontaneous circulation with CPR-ALS was achieved in 11 of
27 animals (41%), requiring 4.2  1.1 countershocks after an
average CPR duration of 6.2  1.9 min. CPB was instituted in
16 animals (59%) without ROSC, following 10 min of CPR-ALS.
Extracorporeal support allowed stable systemic perfusion,
and 6.0  1.5 shocks were needed to achieve successful
conversion in all pigs with CPB.
3.1. Hemodynamic measurements
Hemodynamic data of groups were similar at baseline and
shown in Table 2. Post-resuscitation operative heart rate
( p < 0.001), mean pulmonary artery pressure ( p < 0.001),
and PVRI ( p < 0.01) were significantly increased compared
with baseline. Experimental groups did not differ with
respect to post-resuscitation dopamine support, but use of
HOE-642 resulted in prolonged duration of CPB ( p = 0.046)
and increased need for vasopressor therapy ( p = 0.019)
compared with untreated animals (Table 1). After resuscita-
tion without CPB, HOE-642 treatment resulted in higher CI
( p = 0.061) and lower SVRI ( p = 0.068) compared with
baseline, without reaching statistical difference compared
with untreated animals. Of note, severe vasodilation existed
during CPB following HOE-642 treatment, as higher pump
flows were required to maintain adequate perfusion pressure
compared with the untreated group (Figs. 2—4) at 30 min
(CPB—HOE-642, CI: 3.5  0.5 l min1 m2 vs CPB—no Rx:
2.8  0.4 l min1 m2; p = 0.016) and 60 min (HOE-642, CI:
3.4  0.6 l min1 m2 vs no Rx: 2.5  0.7 l min1 m2;
p = 0.001). Systemic vasodilation persisted after CPB follow-time (min) Dopamine (n/%) Norepinephrine (n/%) Mortality (n/%)
— 4 (67%) 0 1 (16%)
— 1 (20%) 1 (20%) 0
11 7 (78%) 0 2 (22%)
12* 5 (71%) 4 (57%)# 0
(CA) and 10 min of cardiopulmonary resuscitation (CPR-ALS) with or without
ssor support in the CPB group treated with HOE-642 (1 mg/kg). Data are
ardiopulmonary resuscitation; No Rx/HOE-642: animals without or with HOE
Rx/HOE-642: animals without or with HOE treatment after institution of CPB
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Fig. 1. Resuscitation outcome of animals (n = 30) subjected to 15 min of
cardiac arrest (CA) followed by 10 min of cardiopulmonary resuscitation
advanced life support (CPR-ALS). Note: CPR-ALS restored stable circulation
(ROSC) in 40% (12/30) of animals, whereas in 60% (18/30) without ROSC
cardiopulmonary bypass (CPB) was established. No RX: subjects receiving
no treatment; HOE-642: subjects receiving intravenous HOE-642 treatment.
[()TD$FIG]
Fig. 2. Mean arterial pressure of animals on cardiopulmonary bypass (CPB)
with (HOE-642) or without HOE-642 treatment (no Rx). Data are depicted as
mean  standard error of mean (SE).
[()TD$FIG]
Fig. 3. Pump flow index of animals on cardiopulmonary bypass (CPB) with
(HOE-642) or without HOE-642 treatment (no Rx). Note: Higher pump flow was
required to maintain adequate perfusion pressure compared to the untreated
group at 30 and 60 min. Data are depicted as mean  standard error of mean
(SE); (*) compared to baseline values; (#) compared to untreated group (ANOVA
for repeated measurements with the Tukey post-hoc test).ing HOE-642 treatment, as treated animals maintained a
higher CI ( p = 0.014) with decreased SVRI ( p = 0.003)
compared with baseline values despite higher vasopressor
support (Table 1), but missed statistical significance com-
pared with the untreated group (CI: p = 0.094; SVRI:
p = 0.172).
3.2. Mortality
Overall 24-h survival was 89% (24/27), with 91% survival
(10/11) for animals with ROSC during CPR and 88% survival
(14/16) in animals without ROSC and CPB. Mortality did not
differ between treatment groups, with no mortality occur-
ring in both HOE-642 groups (with or without CPB) compared
with 16% (1/6) and 22% (2/9) mortality in pigs with no HOE-
642 treatment and ROSC during CPR (no Rx) or without ROSC
and CPB (CPB and no Rx group), respectively (Table 1).Table 2. Hemodynamic data.
Variable HR (1/min) MAP (mmHg) MPAP (mmHg) CVP (mmHg) PCWP (mmHg) CI (l min1 m2) SVRI (dyn s m5 m2) PVRI (dyn s m5 m2)
Baseline
No Rx 83  12 75  10 15  2 8  3 9  2 3.4  0.8 1598  333 123  73
HOE-642 78  17 70  6 18  1 9  1 10  2 3.2  0.4 1575  269 162  39
CPB and no Rx 90  12 74  6 15  3 8  2 9  2 3.5  0.8 1642  280 151  40
CPB and HOE-642 84  18 72  5 15  3 9  2 9  2 3.2  0.7 1634  281 140  48
After CPB
No Rx 197  10 * 75  10 25  4 * 9  3 10  3 3.3  0.8 1695  509 387  113 *
HOE-642 191  12 * 75  14 29  4 * 10  3 12  3 4.0  0.4 1239  229 351  114 *
CPB and no Rx 190  12 * 68  11 30  7 * 10  3* 11  2 * 3.2  0.7 1488  248 455  74 *
CPB and HOE-642 181  14 * 70  11 31  6 * 11  3* 11  3 4.1  0.9 * 1148  238 * 334  102 *
Hemodynamic variables of treatment groups after 15 min of cardiac arrest (CA) and 10 min of cardiopulmonary resuscitation (CPR-ALS) with or without
cardiopulmonary bypass (CPB). Note: In both HOE-642 (1 mg/kg) treatment group with CPB, cardiac index was increased and vascular resistance indices decreased
after resuscitation compared to baseline values. Data are mean  standard deviation (SD). MAP: mean arterial pressure; MPAP: mean pulmonary artery pressure;
PCWP: pulmonary capillary wedge pressure: CI: cardiac index; SVRI/PVRI: systemic/pulmonary vascular resistance indices; No Rx/HOE-642: animals without or with
HOE treatment after restoration of stable circulation (ROSC) during CPR-ALS; CPB and no Rx/HOE-642: animals without or with HOE treatment after institution of CPB
following unsuccessful CPR-ALS; baseline: before CA.
* p < 0.05 compared to baseline values.
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Fig. 4. Systemic vascular resistance of animals on cardiopulmonary bypass
(CPB) with (HOE-642) or without HOE-642 treatment (no Rx). Note: Systemic
vascular resistance was decreased in animals treated with HOE-642. Data are
depicted as mean  standard error of mean (SE); (*) compared to baseline
values; (#) compared to untreated group (ANOVA for repeated measurements
with the Tukey post-hoc test).
Table 4. Neurologic deficit score and seizures.
Animals (n) 4 h 24 h Seizures (n)
No Rx 5 224  44 195  39 3 (60%)
HOE-642 5 220  43 150  34 * 3 (60%)
CPB and no Rx 7 222  45 202  38 6 (86%)
CPB and HOE-642 7 238  48 162  39 * 4 (57%)
Neurologic deficit score at 4 and 24 h, and post-resuscitation seizure rate was
high in all treatment groups. Note: Neurological score in HOE-642 (1 mg/kg)
treated animals with or without CPB was improved at 24 h compared to 4 h.
Data are mean  standard deviation (SD). No Rx/HOE-642: animals without or
with HOE treatment after restoration of stable circulation (ROSC) during CPR-
ALS; CPB and no Rx/HOE-642: animals without or with HOE treatment after
institution of CPB following unsuccessful CPR-ALS; 4 and 24 h after CPB or
corresponding time point in animals without CPB.
* p < 0.05 compared to baseline values.Excluded in this result overall analysis are three pigs (one
with ROSC, two with CPB) receiving the high HOE-642 doses
(5 mg kg1), which succumbed to severe hypotension due to
vasodilation. These observations were vital to establish the
cariporoide dose that was tested in the other 27 pigs.
3.3. Biochemical measurements
Table 3 summarizes biochemical markers, as CK-MB, AST,
and ALT levels were equally increased after surgery and until
24 h compared with baseline ( p < 0.001) in all treatmentTable 3. Biochemical data.
Variable CD (A/0.5 ml) CK-MB (U/ml) AST
Baseline
No Rx 0.94  0.04 24  1 25
HOE-642 0.94  0.03 25  1 26
CPB and no Rx 0.94  0.02 24  1 26
CPB and HOE-642 0.96  0.02 25  1 24
After CPB
No Rx 1.86  0.34 * 120  37 * 253
HOE-642 1.78  0.35 * 115  32 * 240
CPB and no Rx 1.98  0.23 * 136  29 * 274
CPB and HOE-642 2.05  0.12 * 148  10 * 279
4 h
No Rx 1.80  0.27 * 136  44 * 229
HOE-642 1.57  0.16 * 124  45 * 223
CPB and no Rx 1.84  0.21 * 144  33 * 249
CPB and HOE-642 1.90  0.13 * 162  18 * 247
24 h
No Rx 1.64  0.17 * 113  45 * 204
HOE-642 1.40  0.18 * 93  19 * 214
CPB and no Rx 1.62  0.18 * 113  46 * 203
CPB and HOE-642 1.50  0.17 * 107  31 * 210
Biochemical variables of groups were uniformly elevated after 15 min of cardiac a
cardiopulmonary bypass (CPB). Data are mean  standard deviation (SD). CD: conj
transferase; ALT: alanine amino transferase; ET-1: endothelin 1; NSE: neuron specific
CPR-ALS; no Rx/HOE-642: animals without (n = 5) or with HOE (n = 5) treatment afte
642: animals without (n = 7) or with HOE (n = 7) treatment after institution of CPB fol
corresponding time point in animals without CPB.
* p < 0.001 compared to baseline values.
 byejcts.ctsnetjournals.orgDownloaded from groups, indicating severe tissue damage. Similarly, oxidant
injury measured by CD, and vascular injury (endothelin, ET-1)
were increased in animals after resuscitation ( p < 0.001)
without differences between treatment groups. NSE levels
were significantly elevated in all groups after resuscitation,
with or without CPB. However, NSE values in HOE-treated
animals with CPB tended to decrease at 24 h compared with
untreated subjects ( p = 0.16), but without reaching statis-
tical difference.
3.4. Neurologic function
Overall neurological function was impaired at 4 and 24 h,
with an average score of 227  43 at 24 h and 178  41 at 4 h
( p < 0.001), respectively (Table 4). Although all animals
regained consciousness, there was generalized clonic seizure
activity in 67% (16 of 24 animals) of survivors, without inter-
group differences. HOE-642 treatment, with or without CPB,(U/ml) ALT (U/ml) ET-1 (pg/ml) NSE (ng/ml)
 3 27  3 0.99  0.04 5.6  0.5
 2 27  2 0.99  0.04 5.4  0.4
 2 26  2 0.95  0.06 5.5  0.3
 2 26  2 0.97  0.02 5.6  0.2
 44 * 291  45* 1.78  0.21 * 14.4  1.5 *
 47 * 287  65* 1.88  0.21 * 15.0  1.6 *
 41 * 304  33* 1.94  0.18 * 15.8  1.4 *
 23 * 318  19* 1.99  0.10 * 16.3  1.1 *
 26 * 254  30* 1.79  0.20 * 16.7  2.4 *
 56 * 251  50* 1.80  0.20 * 17.6  3.1 *
 38 * 256  19* 1.87  0.22 * 18.0  2.1 *
 35 * 272  30* 1.93  0.16 * 18.4  1.9 *
 23 * 226  25* 1.74  0.23 * 16.4  2.4 *
 80 * 205  18* 1.63  0.11 * 14.8  1.6 *
 25 214  27* 1.74  0.27 * 17.2  2.3 *
 17 209  29* 1.74  0.24 * 15.3  1.9 *
rrest and 10 min of cardiopulmonary resuscitation (CPR-ALS) with or without
ugated dienes; CK-MB: MB fraction of creatinekinase; AST: aspartate amino
enolase. No Rx: no treatment after restoration of stable hemodynamics during
r restoration of stable circulation (ROSC) during CPR-ALS; CPB and no Rx/HOE-
lowing unsuccessful CPR-ALS; 10 minutes (min), 4 and 24 hours (h) after CPB or
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24 h when compared with 4 h (HOE-642: p = 0.003; CPB and
HOE-642: p < 0.001), and resulted in better consciousness
(cloudy level), positioning, reflexes, and muscle tonus
compared with untreated animals that, however, failed to
reach statistical difference. However, no animal was able to
stand, walk, eat, or drink by itself at 24 h after surgery,
despite HOE-642 treatment.4. Discussion
This study affirmed the capacity of normothermic CPB to
allow near-complete hemodynamic recovery after 15 min of
no-flow CA, as the 37% (10/27) survival after CPR-ALS alone
was extended to 89% (24/27) recovery in animals that would
have succumbed following use of only CPR-ALS. Temporary
CPB successfully salvaged the heart, but severe neurological
damage occurred in survivors that did not receive other
therapy. HOE-642 therapy augmented cardiac output and
reduced the adverse neurological score, but this improve-
ment was quite limited in comparison to the complete
recovery observed in our previous study [10,11]. A potential
culprit is the adverse effect of this agent on vascular tone, as
our preliminary studies showed that profound hemodynamic
vasodilation following the conventional 5 mg kg1 HOE-642
dose allowed complete brain recovery after prolonged
ischemia with DHCA [10,11]. These observations led to the
dose reduction to only 1 mg kg1 HOE-642 bolus followed by a
continuous intravenous infusion of 1 mg kg1 over 30 min that
was tested in this prolonged CA sudden cardiac death model.
HOE-642-treated animals improved post-arrest CI, as
there was no mortality in these animals, but it decreased
vascular resistance, requiring extrinsic vasopressor support
to maintain adequate perfusion pressure. Administration of
the HOE-642 dose of 5 mg kg1 used in prior studies [10,11]
was not possible, as this dosage resulted in 100% mortality in
a preliminary study of three pigs due to fatal hypotension.
Consequently, marked reduction in the dosage was thereby
required to complete this study. No deaths occurred after
adjusting the HOE-642 dose, but vasodilation persisted,
especially in animals undergoing CPB, where higher pump
flows and prolonged CPB perfusion were needed before
discontinuation of bypass was possible.
These findings demonstrate that NHE inhibition markedly
limits vascular tone after prolonged CA, and earmarks the
need for subsequent dose—response studies because the
severe systemic no-flow state in our CPR model makes NHE-
inhibitor drugs act differently than observed in our previous
DHCA studies [10,11]. This supposition was emphasized from
this study, as the 5 mg kg1 HOE-642 dose produced
disastrous hypotension after 15 min of normothermic sudden
death. By contrast, this dose had no adverse effects on
systemic vascular resistance after 90 min of DHCA [10,11],
with near-complete neurological recovery as well as
significant improvement of other ischemic injury markers.
The current study showed that HOE-642 at 1 mg kg1
restricted hypotension but resulted in negligible neurological
improvement at 24-h compared with no-treatment groups.
The role of NHE inhibition is clear from prior information,
as intracellular calcium accumulation after ischemia and byejcts.ctsnetjournals.orgDownloaded from reperfusion plays major role in myocardial stunning and
neurological injury [7—9]. The myocardial benefits of NHE
inhibition are evident from studies showing improved
effectiveness of closed chest CPR, increased resuscitability,
and prevention of post-resuscitation myocardial dysfunction
in pigs subjected to 8 min of untreated VF followed by CPR
[12]. NHE inhibition allows better neuronal energy preserva-
tion by reducing cerebral edema and infarction and
improving neurological recovery, even when given upon
reperfusion following experimental brain reperfusion injury
[12,13]. Heart surgery patients pre-treated with HOE-642
before CPB showed lower serum levels of S-100B and NSE,
suggesting better preservation of the blood—brain barrier
[14]. Of note, the Sodium-Proton Exchange Inhibition to
Prevent Coronary Events in Acute Cardiac Conditions
(EXPEDITION) trial demonstrated a significant reduction of
myocardial necrosis in patients undergoing CABG, who were
treated with the NHE-1 isoform inhibitor, cariporide [15].
However, the same study revealed a marked increase in the
overall incidence of cerebrovascular events from 3% in
placebo-treated to 5.2% in cariporide-treated patients that
was associated with a higher mortality. Although the
underlying reasons for these unexpected findings of the
EXPEDITION trial remain unknown, a higher susceptibility for
ischemic brain injury, resulting from the unique molecular
structure of the drug and the abrupt postoperative with-
drawal of cariporide, was postulated as a possible cause by
the investigators.
Our prior reports support the cardiac and neurological
benefits of NHE inhibition [10,11], but these unequivocal
salutary effects could not be reproduced in the current study,
as HOE-642 treatment had no effect on NSE, and was
associated only with mild neurological improvement. There
are three possible explanations for why HOE-642 did not
exhibit a more profound effect in this study. The first arises
from the increased norepinephrine use in the treated
animals, as a-adrenergic agonists increase NHE sensitivity
and thereby may attenuate neuroprotective effects of HOE-
642 [16]. Furthermore, the lower vascular resistance, along
with the increase dose of norepinephrine, may have led to
inadequate perfusion of the deep brain; hence, the reduced
effect of HOE-642may be secondary to inadequate blood flow
and distribution. Second, the reduced HOE-642 dose of
1 mg kg1 might have been insufficient to inhibit the
reperfusion-related whole-body injury in this model of
prolonged CA. However, we consider the most likely
explanation is related to the timing of HOE-642 administra-
tion. When HOE-642 was effective in these previous studies,
it was given either as a pre-treatment [11], or before
initiation of reperfusion [10]. Conversely, in the present
study, HOE-642 was given after 10 min of CPR, and therefore,
the ischemic tissue had already been exposed to uncontrolled
reperfusion with normal blood. Therefore, significant tissue
reperfusion injury may have already occurred by the time
HOE-642 was administered. Although we could have tested
giving HOE-642 prior to starting CPR, this was not done in the
present study, as this does not simulate the clinical situation
of starting CPR immediately on finding the patient in sudden
death. However, it raises an interesting dilemma, as if we
found that giving HOE-642 before CPR improved results, this
would imply that CPR should not be the initial treatment in Nikola Hristov on December 22, 2011 
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Trummer et al. [17] tested this option of avoiding CPR in
unwitnessed arrest, by employing controlled reperfusion on
CPB without CPR following 15 min of sudden death, and
document complete systemic and neurologic recovery. This
observation implies that reconsideration of avoiding CPR as
the initial treatment in patients with prolonged (unwit-
nessed) sudden death merits further attention.
Evidence of global reperfusion injury following prolonged
CA was garnered from the marked elevation of biochemical
markers of organ injury and persistent neurological damage
at 24 h. We recognize that NHE inhibition was used to
counteract only one component of reperfusion damage (i.e.,
calcium overload), and understand from prior experiments
that many factors must be modified during controlled
reperfusion [7,8] to offset the damage, as shown both in
the heart as well as in our studies following 90 min of DHCA,
where the entire pump prime reperfusate as part of a
multimodal concept (leukocyte depletion, hypocalcemia,
hypermagnesemia, pH-stat strategy, normoxia, mannitol,
and NHE inhibition) was altered [10,18]. Consequently, the
potential for similar results after prolonged CAwill be tested
subsequently by altering many aspects of the prime of the
CPB circuit, including CPB-assisted cooling to mild hypother-
mia, which has been shown clinically to improve neurological
recovery in post-arrest survivors. These future experiments
will determine whether a whole-body (controlled) reperfu-
sate can be useful when an extracorporeal circuit is needed
to support resuscitation in the event of sudden death.
The current study has several limitations that include
absence of confirming the effects of NHE inhibition by
measuring calcium, sodium, and brain edema or to evaluate
neurologic injury by determining apoptosis and/or necrosis.
Neurological deficit score was determined to evaluate the
functional hallmark of brain recovery, but post-arrest serial
assessments of neurological deficit score beyond the 24-h
period (3—7 days post arrest) are needed to determine the
final extent of brain injury and neurological recovery.
Although animals were randomly allocated to treatment
groups before each study, an inherent risk of bias is still
possible, as investigators were not blinded to drug treatment
and a vehicle or placebo administration was not performed in
control animals. We also acknowledge that inefficiency of
NHE inhibition after prolonged CA in our study may have
resulted from inadequate timing of HOE-642 administration
and dosage, with the latter being reduced on an empirical
basis, and due to significant hemodynamic adverse effects of
the drug.
In conclusion, temporary CPB is a useful resuscitative tool
after prolonged CA of 15 min that is unresponsive to CPR-ALS,
and facilitates myocardial recovery and high survival rates,
but fails to improve neurological function. NHE inhibition
during reperfusion may improve neurological recovery, but
adversely variance of vascular resistance will limit its’
potential usefulness. Establishment of a dose—response
curve may potentially define the safe HOE-642 dosage, and byejcts.ctsnetjournals.orgDownloaded from thus might enhance its usefulness following prolonged CA
periods.
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